Suzhou Fushilai Pharmaceutical Co., Ltd. (SHE:301258)
China · Delayed Price · Currency is CNY 33.88
+1.08 (3.29%)
At close: Mar 6, 2026
SHE:301258 Market Cap
SHE:301258 has a market cap or net worth of 3.04 billion as of March 6, 2026. Its market cap has increased by 38.08% in one year.
Market Cap
3.04B
Enterprise Value
1.71B
Revenue
439.57M
Ranking
n/a
PE Ratio
40.30
Stock Price
33.88
Market Cap Chart
Since March 29, 2022, SHE:301258's market cap has decreased from 6.10B to 3.04B, a decrease of -50.17%. That is a compound annual growth rate of -16.21%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Mar 6, 2026 | 3.04B | 4.25% |
| Dec 31, 2025 | 2.91B | 35.37% |
| Dec 31, 2024 | 2.15B | -27.24% |
| Dec 29, 2023 | 2.96B | -17.76% |
| Dec 30, 2022 | 3.60B | -41.00% |
| Mar 29, 2022 | 6.10B | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Shanghai Model Organisms Center | 3.42B |
| Guangdong VTR Bio-Tech | 3.31B |
| Cabio Biotech (Wuhan) | 3.25B |
| Shanghai Hile Bio-Technology | 3.17B |
| Novoprotein Scientific | 2.94B |
| Landfar Bio-medicine | 2.91B |
| Jiangsu Sihuan Bioengineering | 2.89B |
| Shanghai Universal Biotech | 2.82B |